Literature DB >> 22357806

Control of cardiovascular variability during undisturbed wake-sleep behavior in hypocretin-deficient mice.

Alessandro Silvani1, Stefano Bastianini, Chiara Berteotti, Viviana Lo Martire, Giovanna Zoccoli.   

Abstract

The central neural mechanisms underlying differences in cardiovascular variability between wakefulness, non-rapid-eye-movement sleep (NREMS), and rapid-eye-movement sleep (REMS) remain poorly understood. These mechanisms may involve hypocretin (HCRT)/orexin signaling. HCRT signaling is linked to wake-sleep states, involved in central autonomic control, and impaired in narcoleptic patients. Thus, we investigated whether HCRT signaling plays a role in controlling cardiovascular variability during spontaneous behavior in HCRT-deficient mice. HCRT-ataxin3 transgenic mice lacking HCRT neurons (TG), knockout mice lacking HCRT peptides (KO), and wild-type controls (WT) were instrumented with electrodes for sleep recordings and a telemetric blood pressure transducer. Fluctuations of systolic blood pressure (SBP) and heart period (HP) during undisturbed wake-sleep behavior were analyzed with the sequence technique, cross-correlation functions, and coherent averaging of SBP surges. During NREMS, all mice had lower SBP variability, greater baroreflex contribution to HP control at low frequencies, and greater amplitude of the central autonomic and baroreflex changes in HP associated with SBP surges than during wakefulness. During REMS, all mice had higher SBP variability and depressed central autonomic and baroreflex HP controls relative to NREMS. HP variability during REMS was higher than during NREMS in WT only. TG and KO also had lower amplitude of the cardiac baroreflex response to SBP surges during REMS than WT. These results indicate that chronic lack of HCRT signaling may cause subtle alterations in the control of HP during spontaneous behavior. Conversely, the integrity of HCRT signaling is not necessary for the occurrence of physiological sleep-dependent changes in SBP variability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357806     DOI: 10.1152/ajpregu.00668.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Male prairie voles display cardiovascular dipping associated with an ultradian activity cycle.

Authors:  Robert Lewis; J Thomas Curtis
Journal:  Physiol Behav       Date:  2016-01-15

2.  Modulation of sympathetic vasoconstriction is critical for the effects of sleep on arterial pressure in mice.

Authors:  Viviana Lo Martire; Alessandro Silvani; Sara Alvente; Stefano Bastianini; Chiara Berteotti; Alice Valli; Giovanna Zoccoli
Journal:  J Physiol       Date:  2018-01-19       Impact factor: 5.182

Review 3.  The link between narcolepsy and autonomic cardiovascular dysfunction: a translational perspective.

Authors:  Chiara Berteotti; Alessandro Silvani
Journal:  Clin Auton Res       Date:  2017-10-10       Impact factor: 4.435

4.  Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons.

Authors:  Viviana Lo Martire; Alessandro Silvani; Stefano Bastianini; Chiara Berteotti; Giovanna Zoccoli
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

5.  The hypocretins (orexins) mediate the "phasic" components of REM sleep: A new hypothesis.

Authors:  Pablo Torterolo; Michael H Chase
Journal:  Sleep Sci       Date:  2014-08-20

6.  Physiological Mechanisms Mediating the Coupling between Heart Period and Arterial Pressure in Response to Postural Changes in Humans.

Authors:  Alessandro Silvani; Giovanna Calandra-Buonaura; Blair D Johnson; Noud van Helmond; Giorgio Barletta; Anna G Cecere; Michael J Joyner; Pietro Cortelli
Journal:  Front Physiol       Date:  2017-03-27       Impact factor: 4.566

7.  Chromosome duplication (14q) and the genotype phenotype correlation.

Authors:  Ariane Sadr-Nabavi; Morteza Saeidi
Journal:  Int J Fertil Steril       Date:  2014-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.